Pfizer Consumer Health True To Form Pending Move To JV With GSK

摘要

T wo straight years of growth for Pfzer Inc.’s consumer health prod- uct sales aren’t giving it second thoughts about moving the business into a joint venture with GlaxoSmithKline PLC. Instead, those results, following a fat year in 2016 and a dip in 2015, confrm Pfzer’s view of consumer health as a re- liable revenue stream but not a strong growth driver.